Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Asian populations have a lower rate of high-risk gene mutations of venous thrombosis, which means a reasonable perioperative anticoagulant management after hip or knee arthroplasty for Caucasian populations may be too excessive for Asians. So, individual patient risk assessment, rather than a "blanket policy", is considered the best thromboembolism prophylaxis for Asians.The purpose of this study was to evaluate the effectiveness and safety of selective thromboembolism prophylaxis compared with conventional thromboembolism prophylaxis by risk stratification with thromboelastography (TEG) after joint arthroplasty for Asian populations.
Asian patients who underwent hip or knee arthroplasty in Guangdong General Hospital from August 2016 to August 2017 were randomly divided into selective anticoagulation group (SAG) and conventional anticoagulation group (CAG). SAG used anticoagulant when TEG indicated hypercoagulability while CAP used anticoagulant until one month after surgery regularly. Data including patients' basic information, postoperative complications, perioperative clotting index, intraoperative blood loss, perioperative TEG, volume of drainage, and blood transfusion were evaluated.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| selective anticoagulation group | Experimental | Selective anticoagulation group used anticoagulant when thromboelastogram（TEG） indicated hypercoagulability. TEG was performed 1 day before the surgery, 1 day after the surgery, 3 days after the surgery, and 5 days after the surgery. The dosage regimen of anticoagulant was hypodermic injection 0.4 ml low molecular weight heparin per day for 5 days and oral administration of 10 mg Rivaroxaban until one month after the surgery. |
|
| conventional anticoagulation group | Active Comparator | The Intervention for conventional anticoagulation group was using anticoagulant until one month after surgery routinely. The dosage regimen of anticoagulant was hypodermic injection 0.4 ml low molecular weight heparin per day for 5 days and oral administration of 10 mg Rivaroxaban until one month after the surgery. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| selective anticoagulation | Drug | Selective anticoagulation group used anticoagulant once thromboelastography indicated hypercoagulable state. Conventional anticoagulation group used anticoagulant until one month after surgery routinely. The main difference was that the experimental group did not use anticoagulation if the thromboelastography indicated that the blood coagulation status was normal while the control group use anticoagulation routinely. |
| Measure | Description | Time Frame |
|---|---|---|
| The Incidence of Deep Vein Thrombosis | Measured by ultrasound, | 1 day after surgery |
| The Incidence of Deep Vein Thrombosis | Measured by ultrasound | 3 days after surgery |
| The Incidence of Deep Vein Thrombosis | Measured by ultrasound | 5 days after surgery |
| The Incidence of Deep Vein Thrombosis | Measured by ultrasound | 1 month after surgery |
| The Incidence of Deep Vein Thrombosis | Measured by ultrasound | 3 months after surgery |
| The Incidence of Deep Vein Thrombosis | Measured by ultrasound | 6 months after surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Hematocrit | Measured by Complete Blood Count | 1 day before surgery |
| Hematocrit | Measured by Complete Blood Count | 1 day after surgery |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020246 | Venous Thrombosis |
| ID | Term |
|---|---|
| D013927 | Thrombosis |
| D016769 | Embolism and Thrombosis |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D013916 | Thrombelastography |
| ID | Term |
|---|---|
| D001780 | Blood Coagulation Tests |
| D006403 | Hematologic Tests |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| Hematocrit | Measured by Complete Blood Count | 3 days after surgery |
| Hematocrit | Measured by Complete Blood Count | 5 days after surgery |
| Hemoglobin | Number of Hemoglobin Measured by Blood Test | 1 day before surgery |
| Hemoglobin | Number of Hemoglobin Measured by Blood Test | 1 day after surgery |
| Hemoglobin | Number of Hemoglobin Measured by Blood Test | 3 days after surgery |
| Hemoglobin | Number of Hemoglobin Measured by Blood Test | 5 days after surgery |
| Red Blood Cell | Number of Red Blood Cell Measured by Complete Blood Count | 1 day before surgery |
| Red Blood Cell | Number of Red Blood Cell Measured by Complete Blood Count | 1 day after surgery |
| Red Blood Cell | Number of Red Blood Cell Measured by Complete Blood Count | 3 days after surgery |
| Red Blood Cell | Number of Red Blood Cell Measured by Complete Blood Count | 5 days after surgery |
| Volume of Transfusion | Volume of Blood Transfusion | During Hospitalization |
| Transfusion Rate | Number of patients who receive transfusion divided by total number of patients in the group | During Hospitalization |
| Superficial Infection | Number of patients who suffer superficial infection | During Hospitalization |
| Superficial Infection | Number of patients who suffer superficial infection | 1 month after surgery |
| Superficial Infection | Number of patients who suffer superficial infection | 3 months after surgery |
| Superficial Infection | Number of patients who suffer superficial infection | 6 months after surgery |
| Deep Infection | Number of patients who suffer deep infection | During Hospitalization |
| Deep Infection | Number of patients who suffer deep infection | 1 month after surgery |
| Deep Infection | Number of patients who suffer deep infection | 3 months after surgery |
| Deep Infection | Number of patients who suffer deep infection | 6 months after surgery |
| Ecchymosis incidence Rate | Number of patients who suffer ecchymosis divided by total number of patients in the group | 1 month after surgery |
| D003933 | Diagnosis |
| D008919 | Investigative Techniques |